Efficacy and Safety of Valganciclovir in Congenital Cytomegalovirus Infection with Isolated Intrahepatic Cholestasis: A Randomized Controlled Trial

키워드

참고문헌 (56)

1. Hasosah MY, "Perinatal cytomegalovirus hepatitis in Saudi infants : a case series", Saudi J Gastroenterol, 18, pp.208~213 (2012)
2. Yang L, "Comparative effects of valganciclovir and ganciclovir on the congenital cytomegalovirus infection and hearing loss : a randomized controlled trial", Iran J Pediatr, 32, pp.e118874~ (2022)
3. Brooks GF, "Jawetz, Melnick & Adelberg’s medical microbiology", pp.480~483 (2013), McGraw-Hill
4. Puspita G, "Predictor of liver biochemistry improvement in patients with cytomegalovirus cholestasis after ganciclovir treatment", Pediatr Gastroenterol Hepatol Nutr, 25, pp.70~78 (2022)
5. Ruby NA, "Efficacy and tolerability of valganciclovir 6 months vs 6 weeks in symptomatic cytomegalovirus infection in infants : an open level randomized controlled trial", Eur J Clin Med, 3, pp.18~25 (2022)
6. Kenneson A, "Review and meta-analysis of the epidemiology of congenital cytomegalovirus(CMV)infection", Rev Med Virol, 17, pp.253~276 (2007)
7. Bhattacharya D, "Clinical profile of symptomatic congenital cytomegalovirus infection : cases from a tertiary hospital in north India", Trop Doct, 50, pp.282~284 (2020)
8. Schopfer K, "Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy", Arch Dis Child, 53, pp.536~539 (1978)
9. Stagno S, "Congenital cytomegalovirus infection : occurrence in an immune population", N Engl J Med, 296, pp.1254~1258 (1977)
10. Muller WJ, "Treatment of perinatal viral infections to improve neurologic outcomes", Pediatr Res, 81, pp.162~169 (2017)
11. Leung AK, "Congenital cytomegalovirus infection", J Natl Med Assoc, 95, pp.213~218 (2003)
12. Naing ZW, "Congenital cytomegalovirus infection in pregnancy : a review of prevalence, clinical features, diagnosis and prevention", Aust N Z J Obstet Gynaecol, 56, pp.9~18 (2016)
13. Stagno S, "Breastfeeding and the transmission of cytomegalovirus infections", Ital J Pediatr, 28, pp.275~280 (2002)
14. Nassetta L, "Treatment of congenital cytomegalovirus infection : implications for future therapeutic strategies", J Antimicrob Chemother, 63, pp.862~867 (2009)
15. Dollard SC, "New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection", Rev Med Virol, 17, pp.355~363 (2007)
16. Marsico C, "Congenital cytomegalovirus infection : advances and challenges in diagnosis, prevention and treatment", Ital J Pediatr, 43, pp.38~ (2017)
17. James SH, "Advances in the prevention and treatment of congenital cytomegalovirus infection", Curr Opin Pediatr, 28, pp.81~85 (2016)
18. Bialas KM, "Perinatal cytomegalovirus and varicella zoster virus infections : epidemiology, prevention, and treatment", Clin Perinatol, 42, pp.61~75 (2015)
19. Rousseau T, "Severe fetal cytomegalic inclusion disease after documented maternal reactivation of cytomegalovirus infection during pregnancy", Prenat Diagn, 20, pp.333~336 (2000)
20. Gaytant MA, "Congenital cytomegalovirus infection after recurrent infection : case reports and review of the literature", Eur J Pediatr, 162, pp.248~253 (2003)
21. Liberek A, "Cytomegalovirus disease in neonates and infants—clinical presentation, diagnostic and therapeutic problems—own experience", Med Sci Monit, 8, pp.CR815~20 (2002)
22. Tezer H, "Cytomegalovirus hepatitis and ganciclovir treatment in immunocompetent children", Turk J Pediatr, 50, pp.228~234 (2008)
23. Rawlinson WD, "Congenital cytomegalovirus infection in pregnancy and the neonate : consensus recommendations for prevention, diagnosis, and therapy", Lancet Infect Dis, 17, pp.e177~88 (2017)
24. Luck SE, "Congenital cytomegalovirus : a European expert consensus statement on diagnosis and management", Pediatr Infect Dis J, 36, pp.1205~1213 (2017)
25. Wang C, "Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection", Clin Infect Dis, 52, pp.e11~3 (2011)
26. Townsend CL, "Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom", Clin Infect Dis, 56, pp.1232~1239 (2013)
27. Guerra B, "Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers", Am J Obstet Gynecol, 196, pp.221~ (2007)
28. Liesnard C, "Prenatal diagnosis of congenital cytomegalovirus infection : prospective study of 237 pregnancies at risk", Obstet Gynecol, 95, pp.881~888 (2000)
29. Enders M, "Prenatal diagnosis of congenital cytomegalovirus infection in 115 cases : a 5 years' single center experience", Prenat Diagn, 37, pp.389~398 (2017)
30. Luck SE, "Compartmentalized dynamics of cytomegalovirus replication in treated congenital infection", J Clin Virol, 82, pp.152~158 (2016)
31. Boppana SB, "Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns", N Engl J Med, 364, pp.2111~2118 (2011)
32. de Vries JJ, "Real-time PCR versus viral culture on urine as a gold standard in the diagnosis of congenital cytomegalovirus infection", J Clin Virol, 53, pp.167~170 (2012)
33. "Treatment guideline for infants with congenital CMV disease (cCMV)" (2024)[URL]
34. Chiopris G, "Congenital cytomegalovirus infection : update on diagnosis and treatment", Microorganisms, 8, pp.1516~ (2020)
35. Fatema K, "Efficacy of valganciclovir versus ganciclovir in treatment of symptomatic cytomegalovirus infection in infants : an open-label randomized controlled trial", J Int Child Neurol Assoc, 1, pp.1~8 (2019)
36. Suganuma E, "Efficacy, safety, and pharmacokinetics of oral valganciclovir in patients with congenital cytomegalovirus infection", J Infect Chemother, 27, pp.185~191 (2021)
37. Morioka I, "Oral valganciclovir therapy in infants aged ≤2 months with congenital cytomegalovirus disease : a multicenter, single-arm, open-label clinical trial in Japan", J Clin Med, 11, pp.3582~ (2022)
38. Ozkan TB, "Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis", BMC Gastroenterol, 7, pp.9~ (2007)
39. Na SY, "Cytomegalovirus infection in infantile hepatitis", Pediatr Gastroenterol Hepatol Nutr, 15, pp.91~99 (2012)
40. Rosenthal P, "Liver Disease in Children", pp.232~246 (2007), Cambridge University Press
41. Pickering LK, "Red Book: Report of the Committee on Infectious Diseases", pp.275~280 (2009), American Academy of Pediatrics
42. Meine Jansen CF, "Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir", J Perinat Med, 33, pp.364~366 (2005)
43. Müller A, "Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant", J Perinatol, 28, pp.74~76 (2008)
44. Shoji K, "Is a 6-week course of ganciclovir therapy effective for chorioretinitis in infants with congenital cytomegalovirus infection?", J Pediatr, 157, pp.331~333 (2010)
45. Kashiwagi Y, "Efficacy of prolonged valganciclovir therapy for congenital cytomegalovirus infection", J Infect Chemother, 17, pp.538~540 (2011)
46. Tanaka-Kitajima N, "Ganciclovir therapy for congenital cytomegalovirus infection in six infants", Pediatr Infect Dis J, 24, pp.782~785 (2005)
47. Mattar RH, "Nutritional status and intestinal iron absorption in children with chronic hepatic disease with and without cholestasis", J Pediatr(Rio J), 81, pp.317~324 (2005)
48. Mahmud S, "Etiology and outcome of neonatal cholestasis : an experience in a tertiary center of Bangladesh", Dhaka Shishu(Children)Hospital J, 32, pp.22~26 (2016)
49. Pawłowska J, "The role of cytomegalovirus infection in pathogenesis of neonatal cholestasis", Exp Clin Hepatol, 6, pp.25~29 (2010)
50. Kunno A, "Clinical and histological features of cytomegalovirus hepatitis in previously healthy adults", Liver, 17, pp.129~132 (1997)
51. Greanya ED, "The role of the cytomegalovirus antigenemia assay in the detection and prevention of cytomegalovirus syndrome and disease in solid organ transplant recipients : a review of the British Columbia experience", Can J Infect Dis Med Microbiol, 16, pp.335~341 (2005)
52. Ross SA, "Overview of the diagnosis of cytomegalovirus infection", Infect Disord Drug Targets, 11, pp.466~474 (2011)
53. Lombardi G, "Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection", Eur J Clin Microbiol Infect Dis, 28, pp.1465~1470 (2009)
54. Biron KK, "Antiviral drugs for cytomegalovirus diseases", Antiviral Res, 71, pp.154~163 (2006)
55. Lutz APC, "Enhanced cortical processing of cardio-afferent signals in anorexia nervosa", Clin Neurophysiol, 130, pp.1620~1627 (2019)
56. Kimberlin DW, "Valganciclovir for symptomatic congenital cytomegalovirus disease", N Engl J Med, 372, pp.933~943 (2015)

관련 논문AI추천